UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predicting response to abiraterone acetate (AA): mRNA biomarker analysis of study COU-AA-302

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5058-5058

2014

Volltextzugriff (PDF)

Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion

Cancer chemotherapy and pharmacology, 1980, Vol.5 (1), p.21-26

1980

Volltextzugriff (PDF)

Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer

Cancer chemotherapy and pharmacology, 1994, Vol.33 (5), p.415-419

1994

Volltextzugriff (PDF)

A prospective randomized comparison of protracted infusional 5‐fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A mid‐atlantic oncology program study

Cancer, 1991-01, Vol.67 (1), p.14-19

1991

Volltextzugriff (PDF)

Adverse prognostic effect of N2 disease in treated small cell carcinoma of the lung

The Journal of thoracic and cardiovascular surgery, 1984-10, Vol.88 (4), p.495-501

1984

Volltextzugriff (PDF)

Dichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer : a MAOP study

American journal of clinical oncology, 1991-10, Vol.14 (5), p.442-445

1991

Volltextzugriff (PDF)

Protracted Infusion of 5-FU with Weekly Low-Dose Cisplatin as Second-Line Therapy in Patients with Metastatic Colorectal Cancer Who Have Failed 5-FU Monotherapy

Cancer investigation, 1991, Vol.9 (1), p.27-33

1991

Volltextzugriff (PDF)

Phase II study of iproplatin (CHIP) in previously treated small-cell lung cancer

American journal of clinical oncology, 1989-08, Vol.12 (4), p.355-357

1989

Volltextzugriff (PDF)

Phase II trial of extended indications for resection is small cell carcinoma of the lung

The Journal of thoracic and cardiovascular surgery, 1982-01, Vol.83 (1), p.12-17

1982

Volltextzugriff (PDF)

The Prospect of Disease Control by Surgery Combined with Chemotherapy in Stage I and Stage II Small Cell Carcinoma of the Lung

The Annals of thoracic surgery, 1983-07, Vol.36 (1), p.37-41

1983

Volltextzugriff (PDF)

Histologic alterations in small cell carcinoma of the lung after two cycles of intensive chemotherapy

The Journal of thoracic and cardiovascular surgery, 1984-02, Vol.87 (2), p.283-290

1984

Volltextzugriff (PDF)

Phase II studies of methyl glyoxal bis‐guanylhydrazone (NSC 32946) in carcinoma of the colon and lung

Cancer, 1982-10, Vol.50 (7), p.1258-1261

1982

Volltextzugriff (PDF)

Design for Reliability

1. Aufl., 2012

Volltextzugriff (PDF)

Criteria for the establishment of a new behavioural addiction • Commentary to the debate: “Behavioral addictions in the ICD-11”

Journal of behavioral addictions, 2022-07, Vol.11 (2), p.191-198

2022

Volltextzugriff (PDF)

The essential role of theory in minimizing harm from emerging technologies. Lost in committee?. • Commentary on: Problematic risk-taking involving emerging technologies: A stakeholder framework to minimize harms (Swanton et al., 2019)

Journal of behavioral addictions, 2020-12, Vol.9 (4), p.879-885

2020

Volltextzugriff (PDF)

Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies

Breast cancer research : BCR, 2017-07, Vol.19 (1), p.87-87, Article 87

2017

Volltextzugriff (PDF)

43001 Phase 1 study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB207-AB207

2023

Volltextzugriff (PDF)

The association of centromere amplification and response to trastuzumab in HER2+ metastatic breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1016-1016

2023

Volltextzugriff (PDF)

New Australian guidelines for the treatment of alcohol problems: an overview of recommendations

Medical journal of Australia, 2021-10, Vol.215 (S7), p.S3-S32

2021

Volltextzugriff (PDF)

Social cognitive mediators of the relationship between impulsivity traits and adolescent alcohol use: Identifying unique targets for prevention

Addictive behaviors, 2018-09, Vol.84, p.79-85

2018

Volltextzugriff (PDF)

Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities

Journal of medicinal chemistry, 2008-09, Vol.51 (17), p.5330-5341

2008

Volltextzugriff (PDF)

Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer

British journal of cancer, 2020-10, Vol.123 (8), p.1219-1222

2020

Volltextzugriff (PDF)

The essential role of theory in minimizing harm from emerging technologies. Lost in committee?.

Journal of behavioral addictions, 2020-12, Vol.9 (4), p.879-885

2020

Volltextzugriff (PDF)

Impulsivity-related cognition in alcohol dependence: Is it moderated by DRD2 / ANKK1 gene status and executive dysfunction?

Addictive behaviors, 2014-11, Vol.39 (11), p.1663-1669

2014

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Humans
(24)
Biological And Medical Sciences
(19)
Medical Sciences
(18)
Pharmacology. Drug Treatments
(15)
Oncology
(14)
Pharmacology & Pharmacy
(14)
Animals
(12)
Antineoplastic Agents
(12)
Chemistry, Medicinal
(11)
Male
(11)
Middle Aged
(11)
Aged
(10)
Female
(10)
Mice
(9)
Antineoplastic Agents - Pharmacology
(8)
General Aspects
(8)
Structure-Activity Relationship
(8)
Adult
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predicting response to abiraterone acetate (AA): mRNA biomarker analysis of study COU-AA-302

Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion

Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer

A prospective randomized comparison of protracted infusional 5‐fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A mid‐atlantic oncology program study

Adverse prognostic effect of N2 disease in treated small cell carcinoma of the lung

Dichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer : a MAOP study

Protracted Infusion of 5-FU with Weekly Low-Dose Cisplatin as Second-Line Therapy in Patients with Metastatic Colorectal Cancer Who Have Failed 5-FU Monotherapy

Phase II study of iproplatin (CHIP) in previously treated small-cell lung cancer

Phase II trial of extended indications for resection is small cell carcinoma of the lung

The Prospect of Disease Control by Surgery Combined with Chemotherapy in Stage I and Stage II Small Cell Carcinoma of the Lung

Histologic alterations in small cell carcinoma of the lung after two cycles of intensive chemotherapy

Phase II studies of methyl glyoxal bis‐guanylhydrazone (NSC 32946) in carcinoma of the colon and lung

Design for Reliability

Criteria for the establishment of a new behavioural addiction • Commentary to the debate: “Behavioral addictions in the ICD-11”

Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily

The essential role of theory in minimizing harm from emerging technologies. Lost in committee?. • Commentary on: Problematic risk-taking involving emerging technologies: A stakeholder framework to minimize harms (Swanton et al., 2019)

Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies

43001 Phase 1 study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis

The association of centromere amplification and response to trastuzumab in HER2+ metastatic breast cancer

New Australian guidelines for the treatment of alcohol problems: an overview of recommendations

Social cognitive mediators of the relationship between impulsivity traits and adolescent alcohol use: Identifying unique targets for prevention

Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities

Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer

The essential role of theory in minimizing harm from emerging technologies. Lost in committee?.

Impulsivity-related cognition in alcohol dependence: Is it moderated by DRD2 / ANKK1 gene status and executive dysfunction?

Suchergebnisse filtern